Quaker Partners is an East Coast-focused healthcare investment firm. The funds that we manage pursue a traditional venture capital strategy, leading equity investments in healthcare companies at all stages of development. Our industry expertise includes pharmaceuticals, biotechnology, healthcare services, and medical technologies such as devices, tools and human diagnostics. Since its founding in 2002, Quaker has invested in dozens of innovative, high impact healthcare companies. Quaker manages over $700 million in committed capital, and is currently investing its second fund.
14
Total Investments
8
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
About Quaker Partners
Recent Investments (14)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series D | •••••• | May 2019 | |
| Venture Round | •••••• | May 2019 | |
| Seed Round | •••••• | Apr 2019 | |
| Series A | •••••• | May 2018 | |
| Series C | •••••• | Apr 2018 | |
|
|
Venture Round | •••••• | Oct 2017 |
|
|
Series B | •••••• | Jan 2017 |
|
|
Series B | •••••• | May 2015 |
|
|
Series C | •••••• | Apr 2015 |
|
|
Series B | •••••• | May 2014 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.